Table 2.
Invitro and In vivo evidences of therapeutics benefits offered by kefir “a functional dairy foods.”
| Condition | Activity | Subject | Effect | References |
|---|---|---|---|---|
| In vivo | Anticancer activity | Mice | The consumption of milk kefir and soymilk kefir has been shown to considerably suppress the formation of tumors in mice and dramatically boost IgA levels. | (86) |
| Vitro | Antioxidant activity | – | Kefir has a strong affinity for binding the superoxide radical and the 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical, in addition to its ability to suppress linoleic acid peroxidation. | (93) |
| In vivo | Gut health improvement | Mice(two groups of 6) | Bifidogenic growth is one of the probiotic effects of kefir on the gut’s bacterial population. | (77) |
| Vivo | Antimicrobial properties | Mouse | Antagonistic activity was shown to protect against potentially dangerous microbes (Salmonella typhimurium). | (80) |
| In vitro | Antimicrobial properties | – | Researchers have discovered that Lentilactobacillus kefiri B6 is immune to the harmful effects of bile and exhibits antipathogenic capabilities. | (95) |
| Vivo | Inflammatory bowel disease (IBD) |
Rat | Reduces the amount of diarrhea and damage to the mucosal wall caused by the illness at the macroscopic level. | (96) |